Cargando…
HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines
HE4, also known as WFDC2, is a useful biomarker for ovarian cancer when either used alone or in combination with CA125. HE4 is also overexpressed in endometrial cancer (EC), but its function in cancer cells is not clear. In this study, we investigate the role of HE4 in EC progression. An HE4-overexp...
Autores principales: | Li, Jinping, Chen, Haibin, Mariani, Andrea, Chen, Dong, Klatt, Edward, Podratz, Karl, Drapkin, Ronny, Broaddus, Russell, Dowdy, Sean, Jiang, Shi-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634435/ https://www.ncbi.nlm.nih.gov/pubmed/23502467 http://dx.doi.org/10.3390/ijms14036026 |
Ejemplares similares
-
HE4 Transcription- and Splice Variants-Specific Expression in Endometrial Cancer and Correlation with Patient Survival
por: Jiang, Shi-Wen, et al.
Publicado: (2013) -
HE4 (WFDC2) gene overexpression promotes ovarian tumor growth
por: Moore, Richard G., et al.
Publicado: (2014) -
Microarray Analysis on Gene Regulation by Estrogen, Progesterone and Tamoxifen in Human Endometrial Stromal Cells
por: Ren, Chun-E, et al.
Publicado: (2015) -
WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung
por: Bingle, Lynne, et al.
Publicado: (2006) -
Increased levels of HE4 (WFDC2) in systemic sclerosis: a novel biomarker reflecting interstitial lung disease severity?
por: Zhang, Mingxia, et al.
Publicado: (2020)